| [1] | National Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer （2024 edition）[J]. Journal of Clinical Hepatology, 2024, 40(5): 893-918. doi: 10.12449/JCH240508 |
| [2] | Expert Committee on Hepatology， Doctor Society of Integrative Medicine， Chinese Medical Doctor Association. Expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2024, 40(5): 884-892. doi: 10.12449/JCH240507 |
| [3] | Branch of Hepatobiliary Diseases， China Association of Chinese Medicine. Guideline for traditional Chinese medicine diagnosis and treatment of primary liver cancer[J]. Journal of Clinical Hepatology, 2024, 40(5): 919-927. doi: 10.12449/JCH240509 |
| [4] | Branch of Hepatobiliary Diseases， China Association of Chinese Medicine. Guidelines for traditional Chinese medicine diagnosis and treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 461-472. doi: 10.12449/JCH240305 |
| [5] | Chinese Association of Integrative Medicine, China Association of Chinese Medicine, Chinese Medical Association. Guidelines for the integrated traditional Chinese and Western medicine diagnosis and treatment of acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(7): 1547-1552. doi: 10.3969/j.issn.1001-5256.2023.07.006 |
| [6] | Hongkai XU, Chunfu WANG, Ye ZHANG, Jianqi LIAN. Role of fecal microbiota transplantation in chronic liver diseases[J]. Journal of Clinical Hepatology, 2023, 39(9): 2237-2243. doi: 10.3969/j.issn.1001-5256.2023.09.031 |
| [7] | Chinese Association of Integrative Medicine, Chinese Association of Integrative Medicine, Chinese Medical Association. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2543-2549. doi: 10.3969/j.issn.1001-5256.2023.11.005 |
| [8] | Ziwei GUO, Jiaxin ZHANG, Shuo LI, Xiaobin LI, Shun ZHU, Qian JIN, Xiaoke LI, Yongan YE. Research advances in intestinal flora and the development and prognosis of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2022, 38(5): 1137-1142. doi: 10.3969/j.issn.1001-5256.2022.05.034 |
| [9] | Xujuan LUO, Xue BAI, Zenghui LI, Fan LIU, Hao TANG, Ruoxin LI, Guodong YANG. Clinical effect of fecal microbiota transplantation versus the traditional Chinese medicine Rheum officinale in a rat model of hyperlipidemic acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(12): 2767-2773. doi: 10.3969/j.issn.1001-5256.2022.12.016 |
| [10] | An GAO, Yujing XU, Shengwei LU, Wei SUN, Jianhe GAN. Effect of fecal microbiota transplantation on intestinal flora in mice with acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2021, 37(6): 1379-1385. doi: 10.3969/j.issn.1001-5256.2021.06.031 |
| [11] | Infectious Disease Committee, China Society of Integrated Traditional Chinese and Western Medicine, Liver Disease Committee, China Society of Integrated Traditional Chinese and Western Medicine, Branch of Hepatobiliary Diseases, China Association of Chinese Medicine. Recommendations for integrated traditional Chinese and Western medicine diagnosis and treatment of HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2019, 35(6): 1215-1221. doi: 10.3969/j.issn.1001-5256.2019.06.009 |
| [12] | China Association of Chinese Medicine. Guidelines for clinical diagnosis and treatment of acute-on-chronic liver failure in traditional Chinese medicine[J]. Journal of Clinical Hepatology, 2019, 35(3): 494-503. doi: 10.3969/j.issn.1001-5256.2019.03.009 |
| [13] | Hepatobiliary Specialized Committee of China Association of Chinese Medicine, Liver Diseases Specialized Committee of China Medical Associa- tion of Minorities. The clinical guidelines of diagnosis and treatment of chronic hepatitis B with traditional Chinese medicine(2018)[J]. Journal of Clinical Hepatology, 2018, 34(12): 2520-2525. doi: 10.3969/j.issn.1001-5256.2018.12.007 |
| [14] | Deng ChaoWen, Gong ZhengHua, Hu GuoXin. An excerpt of Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis(2016)[J]. Journal of Clinical Hepatology, 2017, 33(3): 413-416. doi: 10.3969/j.issn.1001-5256.2017.03.002 |
| [15] | Li Zhao, Zhu JiYe. An interpretation of diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. Journal of Clinical Hepatology, 2017, 33(9): 1655-1657. doi: 10.3969/j.issn.1001-5256.2017.09.006 |
| [16] | National Health and Family Planning Commission of the People’s Republic of China;. Diagnosis, management, and treatment of hepatocellular carcinoma (V2017)[J]. Journal of Clinical Hepatology, 2017, 33(8): 1419-1431. doi: 10.3969/j.issn.1001-5256.2017.08.003 |
| [17] | Chinese Society of Hepatology, Chinese Medical Association . Guidelines on the management of ascites and complications in cirrhosis[J]. Journal of Clinical Hepatology, 2017, 33(10): 1847-1863. doi: 10.3969/j.issn.1001-5256.2017.10.003 |
| [18] | Branch of Hepatobiliary Diseases, China Association of Chinese Medicine, Branch of Chinese Patent Medicine, China Association of Chinese Medicine. Guideline for diagnosis and treatment of herb-induced liver injury[J]. Journal of Clinical Hepatology, 2016, 32(5): 835-843. doi: 10.3969/j.issn.1001-5256.2016.05.003 |
| [19] | Organ Transplantation Branch, Chinese Medical Doctor Association, Chinese Society of Organ Transplantation, Chinese Medical Association. Clinical guidelines for pediatric liver transplantation in China( 2015)[J]. Journal of Clinical Hepatology, 2016, 32(7): 1235-1244. doi: 10.3969/j.issn.1001-5256.2016.07.001 |
| [20] | Ministry of Health of the People's Republic of China. Diagnosis, management, and treatment of hepatocellular carcinoma (V2011)[J]. Journal of Clinical Hepatology, 2011, 27(11): 1141-1159. |
DownLoad: